NEWS

News, Milestones & Media

Explore Quris’s major announcements, company milestones and coverage across the global media.

quris in the spotlight

Quris in the Spotlight

Breakthrough science. Industry recognition. Global attention.

SCRIP INNOVATION AWARD

Closing the Clinical Prediction Gap

Winner · 2023

The 2023 Scrip Awards recognised Quris-AI in the Innovation Award category.

The Scrip announcement

Nature CommunicationsFEATURED RESEARCH

Six-compound cocktail for maturation of human pluripotent stem cell-derived liver spheroids for toxicity prediction

2026 · Open access

Read the paper

THE QURIS STORY

Science, Vision and the Future of Drug Development

Film · 2 min

Watch the film

FINANCIAL TIMES · SEPTEMBER 2023

How Science is Getting Closer to a World Without Animal Testing

Read in the FT

Fierce BiotechFIERCE BIOTECH · FEBRUARY 2022

Merck KGaA Taps Quris' Stem-Cell-Powered Drug-Screening AI

Read in Fierce Biotech

BROADCAST · 2023

Quris on Inside The Blueprint

Aired on Bloomberg TV and Fox Business, March 2023

Watch the segment

news & press

Milestones & Media Coverage.

Major milestones, each linked to its original source.

Collaboration

Company announcementJanuary 7, 2025

Featured

Merck KGaA Integrates Quris-AI's BioAI Platform

Following an earlier validation collaboration, Merck KGaA integrated Quris-AI's BioAI platform into its preclinical drug safety evaluation workflow.

Read the release on GlobeNewswire

Quris scientists working in the laboratory

Announcements

Newest first

October 29, 2024

Quris-AI Acquires Nortis

Kidney-on-Chip models join the BioAI platform, with public access opened to its microphysiology systems database.

GlobeNewswire

September 28, 2023

Merck KGaA, Darmstadt, Germany Expands Collaboration with Quris-AI

The collaboration was extended after a preclinical study of Quris-AI toxicity predictions against traditional methods.

GlobeNewswire

World's Most Innovative Companies

March 2, 2023

Fast Company Names Quris-AI Among the World's Most Innovative Companies

Recognition on Fast Company's 2023 list of the world's most innovative companies.

Quris-AI

MBZUAI · Abu Dhabi

January 18, 2023

Quris-AI and MBZUAI Announce Bio-AI Center in Abu Dhabi

Quris-AI and Mohamed bin Zayed University of Artificial Intelligence announced a collaboration to develop a Bio-AI center in Abu Dhabi, bringing together artificial intelligence and human biological models for drug development research.

GlobeNewswire

SoftBank Vision Fund 2

December 20, 2022

Additional $9 Million Seed Funding Led by SoftBank Vision Fund 2

A further $9 million brought the seed round to $37 million.

Quris-AI

October 18, 2021

Quris Launches Its Clinical Prediction AI Platform

Company launch with a $9 million seed round.

Quris-AI

In the press

Independently published

BioSpace

Merck KGaA integrates Quris-AI's Bio-AI platform for preclinical drug safety

January 2025

TechCrunch

Quris combines AI with ‘patient on a chip’ to speed drug development and reduce animal testing

October 2021

Quris: the AI pharmacist

October 2021

featured coverage & interviews

Featured Coverage & Interviews

Independent perspectives, industry conversations and international coverage of Quris-AI.

InterviewLab ManagerFebruary 2025

Predicting Patient Safety in Clinical Trials Through Bio-AI Technology

An interview with Quris founder and CEO Isaac Bentwich exploring BioAI, drug safety and the company's pharmaceutical collaborations.

Read the interview

VideoNYSE.tv2023

Quris in the Media

Selected coverage across international and Israeli media, including interviews, articles and broadcast segments. Each item links to its original source.

Fast Company Middle East

This startup aims to replace animal testing and personalize medicine

Feature on the Quris mission.

Mar 2023 Axios

Quris eyeing up to $100M in new funds

Fundraising report, subscription title.

Jan 2023 Fierce Pharma

2023 forecast: an 'inflection point' for biopharma, fueled by AI and machine learning products

Industry forecast citing Quris.

Jan 2023

News, Milestones & Media

Quris in the Spotlight

Closing the Clinical Prediction Gap

Six-compound cocktail for maturation of human pluripotent stem cell-derived liver spheroids for toxicity prediction

Science, Vision and the Future of Drug Development

How Science is Getting Closer to a World Without Animal Testing

Merck KGaA Taps Quris' Stem-Cell-Powered Drug-Screening AI

Quris on Inside The Blueprint

Milestones & Media Coverage.

Merck KGaA Integrates Quris-AI's BioAI Platform

Announcements

Quris-AI Acquires Nortis

Merck KGaA, Darmstadt, Germany Expands Collaboration with Quris-AI

Fast Company Names Quris-AI Among the World's Most Innovative Companies

Quris-AI and MBZUAI Announce Bio-AI Center in Abu Dhabi

Additional $9 Million Seed Funding Led by SoftBank Vision Fund 2

Quris Launches Its Clinical Prediction AI Platform

In the press

Merck KGaA integrates Quris-AI's Bio-AI platform for preclinical drug safety

Quris combines AI with ‘patient on a chip’ to speed drug development and reduce animal testing

Quris: the AI pharmacist

Featured Coverage & Interviews

Predicting Patient Safety in Clinical Trials Through Bio-AI Technology

Quris-AI on NYSE.tv

Quris-AI Featured in The Futurist

Quris-AI Featured on i24 News

Quris in the Media

This startup aims to replace animal testing and personalize medicine

Quris eyeing up to $100M in new funds

2023 forecast: an 'inflection point' for biopharma, fueled by AI and machine learning products